Scientists remeasure a second; Black cancer patients detail clinical trials bias

Scientists rely on the element Cesium to officially measure a second — and it's due for an update. Time researcher Elizabeth Donley explains. And, many Black cancer patients say they're not being offered the chance to join clinical trials at the same rate as other groups. STAT's Angus Chen talks about a new survey of Black cancer patients that raises questions about institutional bias in treatment.